logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10822336 B1

PDFFull Text
Expired
Date of Patent:
Nov. 03, 2020

Filed:

Sep. 28, 2017

Crystals of [2-(1-methyl-1h-pyrazol-4-yl)-6(morpholin-4-yl)-9h-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone and pharmaceutically acceptable salt thereof

Applicant:

Daiichi Sankyo Company, Limited, Chuo-ku, Tokyo, JP;

Inventors:

Yasushi Ueda, Shinagawa-ku, JP;

Sagar Ramdas Amale, Shinagawa-ku, JP;

Manjunath Govind Bhovi, Shinagawa-ku, JP;

Assignee:

Daiichi Sankyo Company, Limited, Tokyo, JP;

Attorney:

Christensen O'Connor Johnson Kindness PLLC

Primary Examiner:

Leslie A Royds Draper

Int. Cl.
CPC ...
C07D 473/34 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 19/02 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 37/02 (2006.01); A61P 17/06 (2006.01); A61K 31/5377 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 473/34 (2013.01); A61K 31/5377 (2013.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 17/06 (2018.01); A61P 19/02 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 37/02 (2018.01); A61P 37/06 (2018.01); A61P 37/08 (2018.01); C07B 2200/13 (2013.01);
Abstract

Provided are novel crystals of [2-(1-methyl-1H-pyrazol-4-yl)-6-(morpholin-4-yl)-9H-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone and a pharmaceutically acceptable salt thereof having advantageous characteristics. [2-(1-Methyl-1H-pyrazol-4-yl)-6-(morpholin-4-yl)-9H-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone and a pharmaceutically acceptable salt thereof provided by the present invention are excellent in stability and have satisfactory physical properties as a drug substance of a pharmaceutical product.

Find Patent Forward Citations

Ueda, Yasushi. (2020). Crystals of [2-(1-methyl-1h-pyrazol-4-yl)-6(morpholin-4-yl)-9h-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone and pharmaceutically acceptable salt thereof (U.S. Patent No. 10822336). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10822336

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…